|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: TELEPHONE & DATA SYSTEMS INC VOTING TRUST 1989, SC 13D, EX-99.1, 2000-08-02 |
Next: SANGSTAT MEDICAL CORP, 8-K, EX-99.1, 2000-08-02 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 27, 2000
SANGSTAT MEDICAL CORPORATION (Exact name of registrant as specified in its charter)
|
|
|
|
|
|
6300 Dumbarton Circle
Fremont, California 94555
(Address of principal executive offices including zip code)
510-789-4300
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Item 5. Other Matters
On July 27, 2000, the Company issued a press release announcing a global settlement agreement entered into with Novartis AG and Novartis Pharmaceuticals Corporation with respect to the patent infringement lawsuits filed against SangStat in the US and UK regarding SangCya® Oral Solution, USP [MODIFIED] as well as the counterclaim SangStat filed against Novartis Pharmaceuticals Corporation in the US. As part of the settlement agreement, the parties have also entered into a global licensing agreement for SangCya Oral Solution.
The foregoing is discussed in greater detail in the Company's press release, a copy of which is filed herewith as exhibit 99.1
Item 7. Financial Statements and Exhibits
(a) Financial statements of business acquired. - Not applicable
(b) Pro forma financial information. - Not applicable
(c) Exhibits
| Exhibit No | Description |
| 99.1 | Press release dated July 27, 2000 |
SIGNATURES
Pursuant to the requirement of the Security Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: August 2, 2000
| SANGSTAT MEDICAL CORPORATION |
| By: | /s/ Stephen G. Dance |
|
| |
| Stephen G. Dance | |
| Senior Vice President, Finance |
EXHIBIT INDEX
| Exhibit No | Description |
| 99.1 | Press release dated July 27, 2000 |
|
|